Qualigen Therapeutics, Inc. (QLGN)
USD 3.9
(-4.88%)
USD 3.9
(-4.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2020 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.2 Million | 4.98 Million | 5.65 Million | 4.3 Million | 5.55 Million | 5.8 Million |
| Cost of Revenue | 5.2 Million | 4.3 Million | 4.33 Million | 7.18 Million | 3.97 Million | 5.42 Million |
| Gross Profit | -4495.00 | 680.8 Thousand | 1.32 Million | -2.87 Million | 1.57 Million | 378.39 Thousand |
| Operating Expenses | 6.09 Million | 18.62 Million | 23.98 Million | 17.4 Million | 3.08 Million | 1.42 Million |
| Selling, General and Administrative Expenses | 6.09 Million | 11.78 Million | 12.26 Million | 8.42 Million | 1.87 Million | 1.43 Million |
| Research and Development Expenses | 5.2 Million | 6.83 Million | 11.71 Million | 3.55 Million | 1.2 Million | 1.31 Million |
| Other Expenses | - | 1125.00 | 5446.00 | - | 2785.00 | - |
| Cost and Expenses | 11.3 Million | 22.92 Million | 28.31 Million | 24.58 Million | 7.06 Million | 6.84 Million |
| Operating Income | -11.3 Million | -17.94 Million | -22.66 Million | -11.3 Million | -1.5 Million | -1.05 Million |
| Interest Expense | 1.52 Million | 26.64 Thousand | - | - | 283.09 Thousand | - |
| Income Tax Expense | -4793.00 | -265.07 Thousand | 5427.00 | 619.00 | 4000.00 | 4619.00 |
| Earnings before Tax | -12.47 Million | -21.29 Million | -17.89 Million | -20.41 Million | -1.78 Million | -1.19 Million |
| Net Income | -13.41 Million | -21.03 Million | -17.89 Million | -20.41 Million | -1.78 Million | -1.2 Million |
| Earnings Per Share Basic | -2.46 | -5.48 | -6.10 | -28.21 | -2.85 | -2.26 |
| Earnings Per Share Diluted | -2.46 | -5.48 | -6.10 | -28.21 | -2.85 | -2.26 |
| Weighted Average Shares Outstanding | 5.07 Million | 3.83 Million | 2.93 Million | 723.71 Thousand | 627 Thousand | 530.46 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 5.07 Million | 3.84 Million | 2.93 Million | 723.71 Thousand | 627 Thousand | 530.46 Thousand |
| Gross Margin | -0.00 | 0.14 | 0.23 | -0.67 | 0.28 | 0.07 |
| EBIT Margin | -2.17 | -2.86 | -4.78 | -2.59 | -0.23 | -0.12 |
| Profit Margin | -2.58 | -4.22 | -3.17 | -4.74 | -0.32 | -0.21 |
| EBITDA | -11.3 Million | -13.84 Million | -22.66 Million | -11.16 Million | -10.02 Million | -717.86 Thousand |
| Earnings Before Tax Margin | -2.17 | -3.60 | -4.01 | -2.62 | -0.27 | -0.18 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 7.94 Million | 1.62 Million |
| Cost of Revenue | 754.28 Thousand | 364.38 Thousand | 4495.00 | 4495.00 | 5.58 Million | 1.01 Million |
| Gross Profit | -754.28 Thousand | -364.38 Thousand | -4495.00 | -4495.00 | 2.35 Million | 610.48 Thousand |
| Operating Expenses | 1.74 Million | 1.41 Million | 2.26 Million | 11.3 Million | 2.77 Million | 4.16 Million |
| Selling, General and Administrative Expenses | 986.48 Thousand | 1.04 Million | 958.27 Thousand | - | 1.33 Million | 2.83 Million |
| Research and Development Expenses | 754.28 Thousand | 364.38 Thousand | 1.31 Million | - | 1.44 Million | 1.32 Million |
| Other Expenses | 1094.00 | -356.66 Thousand | 5460.00 | - | 33.45 Thousand | 5680.00 |
| Cost and Expenses | 1.74 Million | 1.41 Million | 2.27 Million | 11.3 Million | 2.77 Million | 5.17 Million |
| Operating Income | -1.74 Million | -1.41 Million | -2.27 Million | -11.3 Million | -2.77 Million | -3.55 Million |
| Interest Expense | 263.56 Thousand | 136.55 Thousand | 235.81 Thousand | 1.52 Million | 367.25 Thousand | 377.41 Thousand |
| Income Tax Expense | -1212.00 | 1786.00 | -4793.00 | -4793.00 | 421.51 Thousand | -38.18 Thousand |
| Earnings before Tax | -1.47 Million | -2.03 Million | -2.47 Million | -12.47 Million | -3.23 Million | -3.54 Million |
| Net Income | -1.47 Million | -2.03 Million | -2.46 Million | -12.81 Million | -3.65 Million | -3.46 Million |
| Earnings Per Share Basic | -0.19 | -0.34 | -0.47 | - | -0.72 | -0.69 |
| Earnings Per Share Diluted | -0.19 | -0.34 | -0.47 | - | -0.72 | -0.69 |
| Weighted Average Shares Outstanding | 7.6 Million | 5.94 Million | 5.21 Million | 5.07 Million | 5.05 Million | 5.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.6 Million | 5.94 Million | 5.22 Million | 5.07 Million | 5.05 Million | 5.05 Million |
| Gross Margin | - | - | - | - | 0.30 | 0.38 |
| EBIT Margin | - | - | - | - | -0.33 | -2.34 |
| Profit Margin | - | - | - | - | -0.46 | -2.13 |
| EBITDA | -1.74 Million | -1.41 Million | -2.26 Million | - | -2.65 Million | -3.8 Million |
| Earnings Before Tax Margin | - | - | - | - | -0.35 | -2.18 |
0KXM
0I4T
ECLERX
BALMLAWRIE
JISLJALEQS
SGRY